Search Results

Hydroxychloroquine Suppresses Interferon-inducible Genes and B Cell Activating Factor in Patients With Incomplete and New-onset Systemic Lupus Erythematosus

• Authors : Wietske M Lambers; Hendrika Bootsma; Johanna Westra ...

Subjects: 0301 basic medicine; medicine.medical_specialty; Anti-nuclear antibody

• Source: The Journal of Rheumatology, 48(6), 847-851. J RHEUMATOL PUBL CO

Record details

Mortality, causes of death and influence of medication use in patients with systemic lupus erythematosus vs matched controls

• Authors : Bultink, Irene E M; de Vries, Frank; van Vollenhoven, Ronald F ...

Subjects: Male; glucocorticosteroids; DISEASE-ACTIVITY

• Source: Rheumatology (Oxford, England)Bultink, IEM, de Vries, F, van Vollenhoven, RF & Lalmohamed, A 2020, ' Mortality, causes of death and influence of medication use in patients with

Record details

Use of rituximab as a treatment for systemic lupus erythematosus: retrospective review

• Authors : Machado, Roberta Ismael Lacerda; Scheinberg, Morton Aaron; Queiroz, Maria Yvone Carlos Formiga de

Subjects: Lupus erythematosus, systemic/drug therapy; Antibodies, monoclonal/therapeutic use

• Source: einstein (São Paulo). March 2014 12(1)

Record details

Vagus nerve stimulation as a novel treatment for systemic lupus erythematous: study protocol for a randomised, parallel-group, sham-controlled investigator-initiated clinical trial, the SLE-VNS study

• Authors : Amanda Hempel Zinglersen; Ida Lynghøj Drange; Katrine Aagaard Myhr

Subjects: Vagus Nerve Stimulation; rheumatology; Pain

• Source: Zinglersen, A H, Drange, I L, Myhr, K A, Fuchs, A, Pfeiffer-Jensen, M, Brock, C & Jacobsen, S 2022, ' Vagus nerve stimulation as a novel treatment for systemic

Record details

American College of Rheumatology Provisional Criteria for Clinically Relevant Improvement in Children and Adolescents With Childhood-Onset Systemic Lupus Erythematosus

• Authors : Brunner, Hermine I; Holland, Michael J; Beresford, Michael W ...

Subjects: medicine.medical_specialty; Outcome Assessment; Health Care/methods

• Source: Arthritis Care Res (Hoboken)Arthritis care & research, 71(5), 579-590. John Wiley and Sons Inc.ARTHRITIS CARE & RESEARCHArthritis Care & Research, 71(5), 579-590. John Wiley & Sons

Record details

Impact of COVID-19 pandemic on SLE: beyond the risk of infection

• Authors : Alice Horisberger; Laura Moi; Camillo Ribi

Subjects: lcsh:Immunologic diseases. Allergy; medicine.medical_specialty; ARDS

• Source: Lupus Science & MedicineLupus Science and Medicine, Vol 7, Iss 1 (2020)Lupus science &

Record details

Tricuspid valve stenosis - an serious complication to Port-a-cath / Trikuspidalisstenos - en allvarlig komplikation till Port-a-cath

• Authors : Malm, T; Eliasson, H; Johansson, S

• Source: Läkartidningen. 102(45):3318

Record details

Recent Developments in Biologic Therapies for the Treatment of Patients with Systemic Lupus Erythematosus

• Authors : Pedro L Carreira; David A. Isenberg

Subjects: HCC DAUTOIM; Interferon-alpha / therapeutic use; Antibodies, Monoclonal, Humanized / therapeutic use

• Source: Repositório Científico de Acesso Aberto de PortugalRepositório Científico de Acesso Aberto de Portugal (RCAAP)instacron:RCAAP

Record details

Inhibition of Membrane-Bound BAFF by the Anti-BAFF Antibody Belimumab

• Authors : Michele Vigolo; Laure Willen; Dehlia Chevalley

Subjects: 0301 basic medicine; medicine.medical_treatment; Antibodies, Monoclonal, Humanized/pharmacology

• Source: Frontiers in Immunology, Vol 9 (2018)Frontiers in immunology, vol. 9, pp. 2698Frontiers in ImmunologyFrontiers in Immunology, Vol. 9 (2018) P. 2698

Record details

Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus:results from the British Isles Lupus Assessment Group Biologics Register

• Authors : McCarthy, Eoghan M.; Sutton, Emily; Nesbit, Stephanie

Subjects: 0301 basic medicine; Glucocorticoids/therapeutic use; Male

• Source: British Isles Lupus Assessment Group Biologics Register 2018, ' Short-term efficacy and safety of rituximab therapy in refractory

Record details